U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   FORM 10-KSB

            [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                 SECURITIES EXCHANGE ACT OF 1934 [Fee Required]
                   For the fiscal year ended February 28, 2002

             [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE
                     SECURITIES EXCHANGE ACT OF 1934 [NO FEE
                       REQUIRED] For the transition period
                             from_______ to________
                         Commission File No. 2-88678-NY

                          MEDI-DATA INTERNATIONAL, INC.
                 (Name of small business issuer in its charter)

       NEW YORK                                             11-2653474
 (State or other jurisdiction                            (I.R.S. Employer
      of incorporation)                                   Identification No.)

                20 RED GROUND ROAD, OLD WESTBURY, NEW YORK 11568
                    (Address of principal executive offices)

                    Issuer's telephone number: (516) 626-0360

       Securities registered under Section 12(b) of the Exchange Act: None
         Securities registered under Section 12(g) of the Exchange Act:

                         COMMON STOCK, $0.001 PAR VALUE
                                (Title of Class)

Check whether the issuer (1) filed all reports required to be filed by section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes [ X ] No [ ]


Number of shares outstanding of the issuer's common equity, as of May 15, 2002
       (exclusive of securities convertible into common equity): 9,212,551



                                        1

<PAGE>


                                     PART I

ITEM 1.  BUSINESS DEVELOPMENT

In April 1988, Medi-Data International, Inc. (the "Company") ceased all
operations. When it was operating the Company had devoted its business to
developing a program to monitor the interaction and misuse of prescription
drugs, over-the-counter medication and food supplements. For the years ended
February 28, 2002 and 2001, the Company had no operations nor any income from
operations.

The Company is presently seeking to acquire an operating company either for
cash, stock or a combination thereof. There is no present agreement or
understandings with respect to such a neither acquisition nor can there be any
assurance that the Company can make such an acquisition in the near future.

ITEM 2.  PROPERTIES
The Company does not lease or own any properties.

ITEM 3.  LEGAL PROCEEDINGS
To the Company's knowledge, there are no legal proceedings pending.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
Not applicable.


                                     PART II

ITEM 5.  MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

ITEM 6.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS

RESULTS OF OPERATIONS
For the year ended February 28, 2002 and 2001, the Company has been inactive.
For the year ended February 28, 2002 the Company had as a net loss of $100
compared to a net income of $444 for the year ended February 29, 2001.

LIQUIDITY AND CAPITAL RESOURCES
The Company ceased all previous operations in April 1988, and therefore, for the
years ended February 28, 2002 and 2001 the company had no operations or income
from operations. At February 28, 2002 and 2001 the Company had an accumulated
deficit of $1,059,908 and $1,059,808 respectively.

ITEM 7.  FINANCIAL STATEMENTS
The Company's financial statements are set forth herein.





                                        2

<PAGE>



INDEPENDENT AUDITORS' REPORT



The Board of Directors of
Medi-Data International, Inc.

We have audited the accompanying balance sheet of Medi-Data International, Inc.
as of February 28, 2002 and 2001, and the related statements of operations,
stockholders' deficiency and cash flows for the years then ended. These
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.

We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly in all
material respects, the financial position of Medi-Data International, Inc. as of
February 28, 2002 and 2001 and the results of its operations and its cash flows
for the years in the period ended, are in conformity with generally accepted
accounting principles.




Paritz & Company, P.A.
Hackensack, New Jersey
April 23, 2002







                                        3


<PAGE>

<TABLE>
<CAPTION>


                          MEDI-DATA INTERNATIONAL, INC.
                                  BALANCE SHEET
                                  FEBRUARY 28,



                                                                                   2002                  2001
                                                                                   ----                  ----
                                     ASSETS

<S>                                                                          <C>                   <C>
CURRENT ASSETS
       Cash                                                                  $      444            $      544
       Due from shareholder                                                       4,600                 4,600
                                                                             ----------            ----------

TOTAL ASSETS                                                                 $    5,044            $    5,144
                                                                             ==========            ==========


                      LIABILITIES AND SHAREHOLDERS' DEFICIT

CURRENT LIABILITIES
       Accrued expenses and other current liabilities                        $   61,785            $   61,785
                                                                             ----------            ----------

TOTAL CURRENT LIABILITIES                                                        61,785                61,785

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' DEFICIT

       Common stock, $.001 par value 50,000,000 shares
          authorized, 9,213,051 issued and outstanding                            9,213                 9,213
       Additional paid-in capital                                               993,954               993,954
       Accumulated deficit                                                   (1,059,908)           (1,059,808)
                                                                             ----------            ----------

TOTAL SHAREHOLDERS' DEFICIT                                                     (56,741)              (56,641)
                                                                             ----------            ----------


TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT                                  $    5,044            $    5,144
                                                                             ==========            ==========

</TABLE>


                 See accompanying notes to financial statements.


                                        4


<PAGE>

<TABLE>
<CAPTION>

                          MEDI-DATA INTERNATIONAL, INC.
                             STATEMENT OF OPERATIONS
                     FOR THE FISCAL YEARS ENDED FEBRUARY 28,




                                                                                   2002                2001
                                                                                   ----                ----
<S>                                                                           <C>                 <C>
Costs & Expenses:

Selling, general and administrative                                           $       0           $       0
                                                                              ---------           ---------

Loss before other income and state income taxes                                      (0)                  0
                                                                              ---------           ---------

Other income (expenses):

Other income                                                                        (0)                 544
                                                                              ---------           ---------

Total other income (expense)                                                        (0)                 544
                                                                              ---------           ---------

Income (loss) before state income taxes                                             (0)                 544
                                                                              ---------           ---------

State income taxes                                                                  100                 100
                                                                              ---------           ---------

Net Income (loss)                                                             $    (100)          $     444
                                                                              =========           =========


Income (loss) per share                                                       $  0.0001           $  0.0001
                                                                              =========           =========

Basic and fully diluted shares                                                9,212,551           9,212,551
                                                                              =========           =========

</TABLE>

                 See accompanying notes to financial statements.


                                        5


<PAGE>

<TABLE>
<CAPTION>


                          MEDI-DATA INTERNATIONAL, INC.
                       STATEMENTS OF SHAREHOLDERS' DEFICIT
              FOR THE FISCAL YEARS ENDED FEBRUARY 28, 2002 AND 2001




                                                                       CAPITAL                              TOTAL
                                            COMMON STOCK SHARES       IN EXCESS        ACCUMULATED      SHAREHOLDERS'
                                             SHARES      AMOUNT      OF PAR VALUE        DEFICIT            EQUITY
                                             ------      ------      ------------        -------            ------

 <S>                                       <C>           <C>           <C>             <C>                <C>
 Balance February 28, 2000                 9,212,551     $9,213        $993,954        $(1,060,252)       $(57,085)

 Net loss for the year ended
          February 28, 2001                     -            -             -                   444             444

                                           ------------------------------------------------------------------------
 Balance February 28, 2001                 9,212,551     $9,213        $993,954        $(1,059,808)       $(56,641)


 Net income for the year ended
  February 28, 2002                             -            -             -                  (100)           (100)

                                           ------------------------------------------------------------------------
 Balance February 28, 2002                 9,212,551     $9,213        $993,954        $(1,059,908)       $(56,741)
                                           =========     ======        ========        ============       =========

</TABLE>







                 See accompanying notes to financial statements.


                                        6


<PAGE>

<TABLE>
<CAPTION>


                          MEDI-DATA INTERNATIONAL, INC.
                             STATEMENT OF CASH FLOWS
                     FOR THE FISCAL YEAR ENDED FEBRUARY 28,


                                                                                            2002             2001
                                                                                            ----              ----
<S>                                                                                     <C>               <C>
Cash flows from operating activities:
       Net income (loss)                                                                $  (100)          $   444
                                                                                        -------           -------
       Adjustments to reconcile net loss to net cash provided by (used in)
       operating activities: Increase (decrease) in:

       Other assets                                                                          (0)               (0)
                                                                                        -------           -------
       Increase (decrease) in:
       Accrued expenses and other current liabilities                                        (0)             (201)
                                                                                        -------           -------

                 Net cash provided (used) by operating activities                          (100)              243
                                                                                        -------           -------

Cash flows from financing activities:
       Advances of shareholders' loans                                                       (0)              301
                                                                                        -------           -------

                 Net cash provided by financing activities                                   (0)              301
                                                                                        -------           -------


       Net increase (decrease) in cash and equivalent                                      (100)              544
                                                                                        -------            ------

       Cash and cash equivalents - beginning                                                544               (0)
                                                                                        -------           -------

       Cash and cash equivalents - end                                                  $   444           $   544
                                                                                        =======           =======




                       SUPPLEMENTAL CASH FLOW INFORMATION

       Cash paid for interest and taxes was as follows:                                    2002              2001
                                                                                           ----              ----

                                          Interest                                      $     0           $     0
                                                                                        -------           -------

                                          Taxes                                         $   100           $   100
                                                                                        -------           -------

</TABLE>

                 See accompanying notes to financial statements.


                                        7

<PAGE>


                          MEDI-DATA INTERNATIONAL, INC.
                          NOTES TO FINANCIAL STATEMENTS
              FOR THE FISCAL YEARS ENDED FEBRUARY 28, 2002 AND 2001



         1        SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

                  HISTORY

                  The Company is incorporated under the laws of the State of New
                  York. The Company ceased all activity during the year ended
                  February 28, 1989. The current shareholders acquired the stock
                  of the Company in September 1994 as a vehicle to purchase
                  other companies, if and when such acquisitions become
                  possible.


                  USE OF ESTIMATES

                  The preparation of financial statements in conformity with
                  generally accepted accounting principles requires management
                  to make estimates and assumptions that affect the reported
                  amounts of assets and liabilities and disclosure of contingent
                  assets and liabilities at the date of the financial statements
                  and the reported amounts of revenues and expenses during the
                  reporting period. Actual results could differ from those
                  estimated.


                  PER SHARE DATA

                  Loss per share is based on the weighted average number of
                  shares of common stock outstanding during each period.


         2        INCOME TAXES

                  Federal income taxes have been offset in full, as the Company
                  has operating losses carry forwards for tax purposes. The
                  Company's net operating losses have been substantially reduced
                  in accordance with the Internal Revenue Code 382. State income
                  taxes are based upon capital-based minimum taxes.




                                        8


<PAGE>


                                    PART III


ITEM 9.  DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSON; COMPLIANCE
         WITH SECTION 16(A) OF THE EXCHANGE ACT

The following table sets forth information as of May 10,2002, with respect to
the officers and directors of the Company.

<TABLE>
<CAPTION>


           NAME                  AGE       YEAR FIRST APPOINTED DIRECTOR           OFFICE HELD
  --------------------------- --------- ------------------------------------ --------------------------
      <S>                        <C>                     <C>                    <C>
       Terry Brooks              48                      1994                        President

  --------------------------- --------- ------------------------------------ --------------------------
       Dawn M. Schlegel          32                      2000                   Secretary/Treasurer

  --------------------------- --------- ------------------------------------ --------------------------
</TABLE>


The term of office for each of the above mentioned directors is pursuant to the
by-laws of the Company, it will continue until the next annual meeting of
shareholders and until their respective successors are elected and qualified.


TERRY BROOKS is President and director of the Company. Mrs. Brooks has served as
director  since January 24, 1994 when she became a principal  shareholder of the
Company.  Mrs.  Brooks is principally  engaged in the management of her personal
investments for over five years.

DAWN M.  SCHLEGEL is the Secretary and Treasurer of the Company since January 1,
2000.  Mrs.  Schlegel also serves as the Chief  Financial  Officer of a publicly
traded Company for the past five years.  Mrs. Schlegel became a certified public
accountant  in 1993.  She worked for  Israeloff,  Trattner & Co.  CPA's P.C.,  a
certified public accounting firm for five years prior thereto.


ITEM 10.  EXECUTIVE COMPENSATION
No officer or director of the Company has received compensation as salary for
the years ended February 28, 2002 and 2001.




                                        9

<PAGE>



ITEM 11.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth the beneficial ownership of the Company's common
stock as of May l0, 2002 for each person known by the Company to beneficially
own more than five percent of the shares of the outstanding common stock. The
Company's directors and officers are listed in Item 9.


   NAME OF INDIVIDUAL                                          % OF OUTSTANDING
   OR IDENTITY OF GROUP          NO. OF SHARES OWNED (1)          COMMON STOCK
   --------------------          -----------------------       ----------------

   Terry Brooks                       5,500,000 (2)                   60%
   Terry Brooks IRA                   2,500,000                       27%
   All officers and Directors         5,500,000 (2)                   60%

(1) Based on the information furnished by the beneficial owners. Except as
otherwise indicated herein, each beneficial owner has sole voting power and sole
investment power with respect to all shares owned.


(2) Includes  3,000,000  shares  held  by Mrs. Brooks as custodian for her minor
children.




ITEM 12.  CERTAIN RELATIONSHIP AND RELATED TRANSACTIONS
None.






                                       10


<PAGE>




SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed by the
undersigned, thereunto duly authorized.

Dated:  May 15, 2002                        MEDI-DATA INTERNATIONAL, INC.

                                                   /s/TERRY BROOKS
                                                   -----------------------
                                                   Terry Brooks, President























                                       11